KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,412,336 | $12,711,024 | 7.05% |
| TCG Crossover Management, LLC | 3,395,495 | $30,559,455 | 5.01% |
| VR Adviser, LLC | 2,916,667 | $26,250,003 | 4.20% |
| TANG CAPITAL MANAGEMENT LLC | 2,651,393 | $23,862,537 | 3.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 720,508 | $6,484,572 | 2.01% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $29,149,731 | 1.74% |
| Opaleye Management Inc. | 720,000 | $6,480,000 | 1.55% |
| DAFNA Capital Management LLC | 611,032 | $5,499,288 | 1.50% |
| MPM BioImpact LLC | 761,538 | $6,853,842 | 1.38% |
| Nan Fung Group Holdings Ltd | 204,720 | $1,842,480 | 1.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,034,506 | $18,310,554 | 0.98% |
| Boxer Capital, LLC | 1,650,000 | $14,850 | 0.69% |
| AlphaCentric Advisors LLC | 135,000 | $1,215,000 | 0.67% |
| Affinity Asset Advisors, LLC | 178,292 | $1,604,628 | 0.56% |
| Vivo Capital, LLC | 856,008 | $7,704,072 | 0.53% |
| COMMODORE CAPITAL LP | 312,553 | $2,812,977 | 0.32% |
| HighVista Strategies LLC | 69,567 | $626,103 | 0.29% |
| Birchview Capital, LP | 40,000 | $360,000 | 0.27% |
| Ikarian Capital, LLC | 140,000 | $1,260,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,035,935 | $9,323,415 | 0.12% |
External links
This page lists KALVISTA PHARMACEUTICALS INC's shareholders in Q2 2023. To view KALVISTA PHARMACEUTICALS INC's shareholder history, click here.